John Blythe

John Blythe is a seasoned sales professional with extensive experience in the pharmaceutical and biotech industries, currently serving as a Senior Hematology Clinical Account Specialist at Pharmacyclics, an AbbVie Company, since January 2018, focusing on the sales of Imbruvica for CLL and MCL in the Chicago South territory. Previous roles include Sr. Biopharmaceutical Rep and Regional Sales Trainer at Amgen, Area Sales Executive at Garver Feeds and Distributing, and Sales Director at Caris Diagnostics, where notable achievements included opening 65 accounts in one year while ranking #9 among 24 territories. John Blythe's career also includes impactful positions at Pharmion Corporation, Sanofi-Aventis Oncology, and Immunex Corporation, where John successfully launched Eloxatin as a standard of care and ranked #1 in national sales. John Blythe holds a Bachelor of Science in Marketing from Bradley University.